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ABSTRACT 
Objective:  The objective of this present study was to assess the accuracy, result, and safety measures of 
stereotactic biopsy. The study was conducted at the Neurospinal & Cancer Care Institute Karachi. 
Material and Methods:  After the approval from the ethical hospital committee, the study was conducted on 34 
patients, in which 9 (26.4%) were females, and 25 (73.5%) were males. 34 consecutive patients with biopsy 
inclusion deep seated lesion, mid line pathology, eloquent area and operated surgery, previous radiation 
treatment were excluded, and after that, the biopsy report based surgery or radiotherapy treatment was decided. 
Result:  The biopsy underwent histopathological diagnosis proving Astrocytoma in 7 (20.5%) patients out of 
which four were in the Eloquent area, tuberculosis diagnosed in 5 (14.7%) patient, Oligodendroglioma diagnosed 
in 3 (8.8%) patients, metastasis in 5 (14.7%), Abscess in 4 (11.7%) patient which was aspirated to maximum and 
sent for culture, Malignant tumor (grade 3 & 4) 5 (14.7%), Lymphoma in 2 (5.8%) patient both were given 
radiation therapy Tumor necrosis 1 (2.9%) case,  and No tissue obtained in 2 (5.8%) which was repeated later. 
No major complication or side effects were observed in the patient. 
Conclusion:  Stereotactic Framed biopsy is safe and accurate and can be used in deep seated lesions with high 
success rate, minimal complication and decrease surgical morbidity for patients, and it is comparable to updated 
methods. 
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INTRODUCTION 
A stereotactic brain biopsy is performed to know the 
disease histology before treating patients and selecting 
method of treatment. Usually, manifestation for deep 
seated or inoperable lesions.
1
 Stereotactic surgery has 
gone under innovation from frame-based to the 
frameless system as a result, there is the considerable 
unpredictable role of frameless to the precise accuracy 
advantage of frame-based methods.
2
 The stereotactic 
frame is the best choice for its reliability targeting for 
decades. Despite the restraint of both from framed to 
frameless with time tested, they both have proven 
equally reliable and accurate.
3
 Not as it was a magnetic 
resonance imaging guided stereotactic biopsy, but the 
approach robotic-assisted stereotactic has upgraded the 
security and close perfection of the result. With the 
passage of time, despite of an advancement in radio-
imaging has changed the fade in many ways, accurate 
histological diagnosis is an asset to treatment planning 
and management of intracranial pathologies and with 
the help of frame-based and frameless accuracy is 
around, 66 – 99% in framed biopsy and as 89 – 93% 
respectively in the literature
5
 and minimal rate of 
morbidity and motality.
6
 Frameless stereotactic 
targeting devices may miss target and miss diagnosis 
as compared with standard frame-based stereotaxy.
7
 
Stereotactic frame systems are not only preferred for 
stereotactic biopsy, but are standard for deep brain 
stimulation (DBS) devices and psychological 
disorders.
8
 In Frameless stereotactic neuronavigation, 
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devices are used still yet not and secure as framed 
systems, in terms of targeting lesion biopsies.
9
 Frame 
mounting is considered a significant step in 
stereotactic neurosurgery. Specific points of surface 
anatomy are of utmost importance and are used for 
accuracy.
10
 
 The noble art of performing a stereotactic biopsy 
as minimal invasive can be a safe, accurate, and the 
less morbid method to make a diagnosis which helps 
in managing according to diagnosis, helping to us 
decide mode of treatment, avoiding patient from long 
stay and unwanted surgery. 
 
MATERIAL AND METHODS 
Study Setting 
A descriptive observational study was conducted 
from16-January-2015 to 18-January 2020 at 
Neurospinal &the Cancer Care Institute, Karachi. 
 
Inclusion Criteria 
Deep seated lesion, eloquent area lesions and midline 
pathologies. 
 
Exclusion Criteria 
Previously operated cases, previous radiation 
treatment and coagulopathy. 
 
Data Collection 
The study was permitted by the ethical view board at 
our hospital. Moreover, consent was taken from all the 
patients for this study and data was collected. Proper 
history, neurological examination, CT scans brain and 
MRI brain was done. A total of 34 consecutive 
patients who underwent biopsy and later appropriately 
treated with surgical treatment, conservative or chemo 
radiotherapy was advised. Out of 34 patients, 
distributed as 25 (73.5%) were men and 9 (26.4%) 
were women. The mean age was 61 and the patients 
were between 34 to 84 age. Data were analyzed using 
SSPS version 22 and presented in the form of tables 1 
and 2. 
 
Surgical Procedure 
The biopsies were performed under general anesthesia. 
In all lesions, Famous frame Cosman‐Roberts‐Wells 
(CRW) specialized stereotactic frame was used. The 
stereotactic head frame was fixed, and a fiducial head 
 
Table1:  Location of Lesion. 
 
 Site n = 34 Percentage 
1. Frontal 5 14.7% 
2. Temporal 6 17.6% 
3. Thalamus 12 35.29% 
4. Basal ganglia 4 11.7% 
5. Brain stem 4 11.7% 
6. Cerebellum 3 8.8% 
 
Table 2:  Histopathological Diagnosis. 
 
 Lesion n = 34 Percentage 
1. Astrocytoma 7 20.5% 
2. Oligodendroglioma 3 8.8% 
3. Metastasis 5 14.7% 
4. Malignant tumors 5 14.7% 
5. Abscess 4 11.7% 
6. Radiation necrosis 1 2.94% 
7. Tuberculosis 5 14.7% 
8. Lymphoma 2 5.8% 
9. Target missed 2 5.8% 
 Total 34  
 
box was applied, then the patient was shifted for CT or 
(MRI) brain was to calculate the coordinates 
accordingly (Figure-1). After imaging, the patient was 
shifted to Operation Theater and positioned supine 
with the head fixed. Biopsy was taken through with a 
burr hole, under general anesthesia, burr hole was 
made, the point of the entry point was anterior to their 
coronal structure, 3 cm lateral to mid line and 2.5 cm 
anterior to the coronal suture as it was considered the 
safer surgery method in this area of the human brain. 
As for the Lesion in the brain stem, the perpendicular 
coronal plane to the head ring was performed. The 
direction utilizing was chosen to maintain a strategic 
distance from the ventricles and to decide how distant 
along the side to put the burr gap within the operating 
room. Moreover, coordinates or X, Y, and Z were 
already measured with a CT scan. Plus, the biopsy 
needle distance is measured, and a calculated biopsy 
was taken, and if any cyst or abscess found it was 
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aspirated. Operating time was 120 minutes approx. 
The patients were kept under cover prophylactic anti-
epileptic, ceftriaxone and gentamycin and discharge on 
the 2
nd
 post-operative day. 
 
 
 
Fig. 1: Representation of the XYZ Coordinates Calculation 
on CT Scan. 
 
 
 
Fig. 2: Double Target Calculation for Stereotactic Biopsy 
for Cystic and Solid Part of Tumor. 
 
RESULTS 
The biopsy underwent histopathological diagnosis 
proving Astrocytoma in 7 (20.5%) patients out of 
which three were in the Eloquent area referred for 
Gamma-knife surgery while four cases were operated, 
tuberculosis diagnosed in 5 (14.7%) patient, two 
patient were operated for mass effect while three were 
kept under Anti-tuberculosis treatment till complete 
recovery, Oligodendroglioma diagnosed in 3 (8.8%) 
patients all cases were operated later, metastasis in 5 
(14.7%) patient in 2 was single lesion they write 
operated while, three patients had multiple lesion they 
were referred for chemotherapy and radiotherapy, 
Abscess in 4 (11.7%) patient which was aspirated to 
maximum and sent for culture, Malignant tumor 
(grades 3 & 4) 5 (14.7%) cases out of which three 
were operated due to mass effect and 2 cases were 
treated with chemotherapy, Lymphoma in 2 (5.8%) 
patient, Tumor necrosis 1 (2.9%) case, and No tissue 
obtained in 2 (5.8%) which was repeated later. No 
major complication or side effects were observed in 
the patient. 
 
DISCUSSION 
Bernstein et al,
11
 preformed 300 serial intra-axial brain 
lesion stereotactical biopsies for a total of nineteen 
patients (6.3%) while 5 died during the procedure; 
having a diagnosis of Glioblastoma. Remaining 14 
patients (4.7%) developed neurological deficits due to 
hemorrhage. Mostly mild and of transient type. They 
concluded that Stereotactic biopsy has less 
complication rate and less morbidity compared to 
craniotomy. While, in our study, we had less number 
of the patient, plus we did not observe such major 
complication may be due to a limited number of 
patient studies and experienced faculty. 
 In study of Hall et al,
12
 134 stereotactic brain 
biopsies were conducted. Computed tomography-
guided in 85 patients around (63%) and 49 biopsies of 
patients were performed with the help of magnetic 
resonance imaging around (37%). Right side of 
hemisphere of the brain had a share of 64 pathologies, 
that is 48%, while 61 (45%) in the left,62 were 
malignant brain tumors (46%), 24 were benign brain 
tumors (18%), and 20 were infections (15%) and five 
biopsies (4%), diagnostic yield measurement of 96%. 
However, the neurological shortage after the biopsy 
was conducted, and the morbidity rate was rated at 
0.7%. One patient had a fatal hemorrhage during the 
biopsy process due to the high vascularity of tumor 
while we mostly used CT scan based calculations for 
our study. We did not had any death or morbidity in 
patients, while common lesion biopsies we came 
across was the astrocytoma, followed by malignant
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tumor and metastasis. 
 Lu et al,
13
 had100% constructive diagnosis in all 
50 cases in the magnetic resonance imaging 
intraoperatively iMRI group, although in four cases, 
the biopsy was not accurate from the expected point 
due to which repeat biopsy was done. However, no 
severe complications were observed in the iMRI 
grouping, bleed at the puncture area was noted in 2 
patients within the control group. Moreover, no death 
was recorded in either group. While we only had two 
cases where the target was deviated while similar to 
their study, we did not have any major complications. 
Their study used more advance technique, and we 
stayed will traditional procedures, however the results 
are comparable. 
 Cheng et al,
14
 A total number of 145 patients 
undergo Stereotactic Biopsy among 18 (12.4%) in the 
pineal region,16 (11.0%) sellar part, brainstem had 
111 (76.6%). Biopsy accomplished 16/16 (100%), 
18/18 (100%), and 107/111 (96.4%), the sellar region, 
pineal region, and brainstem were achieved patients, 
respectively. No major complications were 
documented in sellar or pineal, while it occurred in 
brain stem 17/111 patients (15.3%). While in our 
study, we did not have any biopsy from sellar, pineal 
gland we did not receive a sellar or pituitary region 
biopsy while we done brain stem biopsy not had any 
major complication as mentioned in their research 
Hamisch et al,
15
 performed 189 patients with 511 
procedures. Lesions were localized in the thalamus 
(4.3%), Sella (7.8%), basal ganglia (17.0%), 
brainstem, pineal region (11.5%) and corpus callosum 
study had a zero rate of mortality and 0.4% and 9.6% 
was permanent and the transient morbidity rate was 
respectively. While, in 99.2% the Histological analysis 
was possible while compared to our study, 95% 
diagnostic result, while we did not perform much 
procedure on sella, pine all area and, similarly, we had 
no mortality in our study. 
 Sciortino et al,
16
 in their study judgment, was 
performed on 93.6% having 9 biopsies ensuing the 
non-accurate. Hemorrhage occurred in 2.1%. 
Moreover, in this, no procedure had mortality. Five 
days was the average stay in the hospital, with the 
mean surgical time of sixty minutes and compared to 
our study, stay time was two days postoperatively, no 
hemorrhage was observed in the study, and the 
diagnostic point was about 95% diagnostic results 
while similarly no mortality was observe. 
 Smith et al,
17
 did a study on 213 patients, and 
among them there were 74 frameless and 139 frame-
based cases. They found that no major differences 
between two the frameless biopsies and frame-based 
groups when compared to their overall diagnostic 
accuracy, the amount of non-diagnostic procedure, 
demographics, or procedure complications. Mean 
operating time between and frameless and Frame-
based biopsies were 185+/-6 and 114+/-3 minutes, 
respectively. Their study showed that no significant 
difference observed based on this study, both the 
approaches/procedures were effective at equal level. 
While, our study did not have two group studies, we 
performed all studies with the CRW frame based on a 
calculation CT scan with time frame biopsy average 
time 120minutes. 
 Neumann et al,
18
 conducted a retrospective study 
of 500 cases using FBSBs utilizing iMRI were 
compared to a historical control of hundred procedures 
of biopsy with conventional workflows CT and 
magnetic resonance imaging image fusion. Their study 
showed no significant difference in diagnostic and 
complication rate among 2 groups. Hence FBSB 
utilizing 1.5T iMRI is an accurate, effective and yes a 
safe method and provides comparable results to the 
conventional stereotactic method. 
 Nishihara et al
19
 studied about the safety of 
stereotactic biopsy with they performed 58 times in 
fifty-six patients (male: 29, female: 27), 58 biopsies 
diagnoses were recognized, with, 8 of Mets, brain SOL 
thirty-five cases, nine of malignant lymphoma, and 
leukemia, diagnose of germ cell tumor in two patients, 
2 cases of abscess in 2 cases, diagnose of necrosis in 
one case, and one case with normal tissue, hemorrhage 
with in tumor was  in 3 cases (5.2%) also having 
neurological deficits has occurred. They were surgical 
removal and Glioma was diagnosed. In their study, 
thalamus & basal ganglia showed the risk of 
morbidity, while in our study, in contrast we did not 
have any hemorrhage among patient nor neurological 
deficit was found and we used CRW frame by an 
experienced neurosurgeon and no neurological defect. 
 
CONCLUSION 
Stereotactic Framed biopsy is safe and accurate and 
can be used in deep seated lesions with high success 
rate, minimal complication, and decreases a surgical 
morbidity for patients, and it is comparable to updated 
methods. 
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